135 studies found for:    novel influenza a (h1n1)
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Novel Influenza A (H1N1) Surveillance Registry
Conditions: Novel Influenza A;   H1N1;   Influenza
Intervention:
2 Completed Swine Flu (Novel Influenza A H1N1) Vaccine Study
Condition: Influenza
Interventions: Biological: Baxter Novel Influenza A H1N1 Whole Virus Vaccine;   Biological: GlaxoSmithKline Novel Influenza A H1N1 Split Virion Vaccine
3 Recruiting Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)
Condition: Influenza
Intervention:
4 Completed Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study
Condition: Influenza
Interventions: Drug: oseltamivir;   Other: blank;   Drug: chinese medicinal herbs;   Drug: oseltamivir and chinese medicinal herbs
5 Unknown  Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study
Condition: Influenza
Interventions: Drug: oseltamivir;   Drug: oseltamivir and chinese medicinal herbs
6 Completed Antiviral Therapy for Influenza A H1N1
Condition: Influenza A Virus Infection
Intervention:
7 Completed A Clinical Trial With Influenza A/H1N1 Vaccines
Condition: Influenza
Interventions: Biological: split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose;   Biological: split-virion, adjuvanted H1N1 vaccine of 15 μg per dose;   Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg per dose;   Biological: split-virion, non-adjuvanted H1N1 vaccine of 30 μg per dose;   Biological: whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose;   Biological: whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose;   Biological: placebo control
8 Completed Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older
Conditions: Virus Diseases;   Respiratory Tract Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 30 μg;   Biological: Experimental: split-virion, adjuvanted H1N1 vaccine of 7.5 μg;   Biological: Experimental: split-virion, adjuvanted H1N1 vaccine of 15 μg;   Biological: Experimental: split-virion, adjuvanted H1N1 vaccine of 30 μg;   Biological: Experimental: split-virion, non-adjuvanted H1N1 vaccine of 15 μg;   Biological: Placebo Comparator: Placebo control
9 Unknown  Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Interventions: Biological: 7.5ug H1N1 Influenza vaccine;   Biological: 15ug H1N1 vaccine;   Biological: seasonal influenza vaccine
10 Completed Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine
Conditions: Novel Influenza A (H1N1);   A New Flu Virus of Swine Origin
Intervention: Other: Non-intervention observational study
11 Completed
Has Results
Surveillance for Adverse Events Following Pandemic H1N1 Immunization
Condition: Novel Influenza A/H1N1
Intervention:
12 Completed
Has Results
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children
Condition: Influenza Caused by the Novel Influenza A (H1N1) Virus
Intervention: Biological: CSL425
13 Completed
Has Results
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults
Condition: Influenza Caused by the Novel Influenza A (H1N1) Virus
Intervention: Biological: CSL425
14 Enrolling by invitation Follow-up of Immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Healthy Volunteers After 6 Months
Condition: Influenza
Intervention:
15 Completed Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine
Condition: Influenza A (H1N1)
Intervention: Other: This is non-intervention observational study
16 Completed
Has Results
Relenza® Sentinel Site Monitoring Program in Japan
Condition: Influenza, Human
Intervention: Drug: zanamivir
17 Completed
Has Results
Novartis H1N1 Vaccine in Pregnant Women
Condition: Influenza
Intervention: Biological: Inactivated H1N1 Vaccine
18 Completed
Has Results
H1N1 Vaccine in Pregnant Women
Condition: Influenza
Intervention: Biological: Inactivated H1N1 Vaccine
19 Completed Safety of H1N1 Influenza Vaccination in Pregnant Women
Conditions: Virus Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Intervention: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg
20 Recruiting Safety and Efficacy of Investigational Immune Plasma in Treating Influenza A
Condition: Influenza A
Interventions: Biological: Anti-Influenza Plasma;   Behavioral: Standard Care

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years